Association of IL‑17A rs2275913 Polymorphism and Gene Expression in Cutaneous Leishmaniasis
Abstract
Background: Leishmaniasis is a protozoan infectious disease in which host genetic polymorphisms may influence susceptibility and disease severity. We aimed to evaluate the IL‑17A rs2275913 polymorphism and IL‑17 expression in patients with cutaneous leishmaniasis compared with healthy controls in Ilam Province, western Iran.
Methods: Blood samples were obtained from 45 patients with cutaneous leishmaniasis and 45 healthy controls. Cutaneous leishmaniasis was diagnosed microscopically using Giemsa-stained lesion smears, without species-level identification. The IL‑17A (197A>G) rs2275913 polymorphism was genotyped using ARMS‑PCR, and IL‑17 mRNA expression in peripheral blood was quantified by real‑time PCR.
Results: Of the 45 patients with cutaneous leishmaniasis, 28.9% were female and 71.1% were male. Most patients had one to two lesions, mainly located on the hands and feet. There was no significant difference in the distribution of IL‑17A rs2275913 genotypes and alleles between patients and controls (P>0.05). In contrast, IL‑17 expression was significantly elevated in patients, showing a 4.6‑fold increase compared with controls (P<0.001).
Conclusion: The rs2275913 polymorphism does not appear to be associated with susceptibility to cutaneous leishmaniasis. Although the sample size was relatively small, the marked upregulation of IL-17 expression highlights the active involvement of the IL-17 pathway in host immune responses and the inflammatory milieu of cutaneous leishmaniasis, likely reflecting immune modulation rather than direct pathogenesis.
2. Hotez PJ. Human parasitology and parasitic diseases: heading towards 2050. Adv Parasitol. 2018;100:29-38.
3. Pareyn M, Dvorak V, Halada P, et al. An integrative approach to identify sand fly vectors of leishmaniasis in Ethiopia by morphological and molecular techniques. Parasit Vectors. 2020;13(1):580.
4. Dubie T, Mohammed Y. Review on the role of host immune response in protection and immunopathogenesis during cutaneous leishmaniasis infection. J Immunol Res. 2020;2020:2496713.
5. de Albuquerque SdCG, da Costa Oliveira CN, Vaitkevicius-Antão V, et al. Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis. Cytokine. 2019;123:154784.
6. Hammad A, Mosaad YM, Hammad EM, et al. Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis. Autoimmunity. 2016;49(1):31-40.
7. Holster A, Teräsjärvi J, Lauhkonen E, et al. IL-17A gene polymorphism rs2275913 is associated with the development of asthma after bronchiolitis in infancy. Allergol Int. 2018;67(1):109-113.
8. Medrano RFV, De Oliveira CA. Guidelines for the tetra-primer ARMS–PCR technique development. Mol Biotechnol. 2014; 56(7):599-608.
9. Ye S, Dhillon S, Ke X, Collins AR, Day IN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res. 2001;29(17):E88-8.
10. Pitta MG, Romano A, Cabantous S, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest. 2009;119(8):2379-87.
11. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44-9.
12. Khatonier R, Khan AM. Genetic variations in interleukin-17 gene: a review on SNP rs2275913 and its clinical implications. Gene. 2025; 967: 149708.
13. Sadighi S, Bazmany A, Babaloo Z, Amadi H. Evaluation of interleukin 17: A polymorphism in patients with visceralleishmaniasis. J Res Clin Med. 2014;2(2):77-82.
14. Khatonier R, Khan AM, Sarmah P, Ahmed G. Role of IL-17 gene polymorphism in Indian kala-azar. J Vector Borne Dis. 2020;57(1):23-30.
15. Banerjee A, Bhattacharya P, Joshi AB, et al. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines. Cell Immunol. 2016;309:37-41.
16. Lopez Kostka S, Dinges S, Griewank K, et al. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol. 2009;182(5):3039-46.
17. Novoa R, Bacellar O, Nascimento M, et al. IL‐17 and Regulatory Cytokines (IL‐10 and IL‐27) in L. braziliensis Infection. Parasite Immunol. 2011;33(2):132-6.
18. Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279.
19. Leon Rodriguez D, Echeverria L, González C, Martin J. Investigation of the role of IL17A gene variants in Chagas disease. Genes Immun. 2015;16(8):536-40.
20. Miyazaki Y, Hamano S, Wang S, et al. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol. 2010;185(2):1150-7.
21. Milano M, Moraes MO, Rodenbusch R, et al. Single nucleotide polymorphisms in IL17A and IL6 are associated with decreased risk for pulmonary tuberculosis in Southern Brazilian population. PLoS One. 2016;11(2):e0147814.
22. Tayefinasrabadi H, Mohebbi SR, Hosseini SM, et al. Association of Interleukin-17 gene polymorphisms with susceptibility to chronic hepatitis B virus infection and clearance in Iranian population. Microb Pathog. 2020;144:104195.
23. Espinoza JL, Takami A, Nakata K, et al. A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One. 2011;6(10):e26229.
24. Alexander J, Brombacher F. T helper1/t helper2 cells and resistance/susceptibility to Leishmania infection: is this paradigm still relevant? Front Immunol. 2012;3:80.
25. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223(1):87-113.
26. Shibata T, Tahara T, Hirata I, Arisawa T. Genetic polymorphism of interleukin-17A and-17F genes in gastric carcinogenesis. Human Immunol. 2009;70(7):547-51.
27. Rasouli M, Asaei S, Kalani M, Kiany S, Moravej A. Interleukin-17A genetic variants can confer resistance to brucellosis in Iranian population. Cytokine. 2013; 61(1):297-303.
| Files | ||
| Issue | Vol 21 No 4 (2026) | |
| Section | Original Article(s) | |
| Keywords | ||
| Cutaneous leishmaniasis IL‑17A rs2275913 Genetic polymorphism ARMS‑PCR | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

